INSTRUCTIONS TO PATIENT Explain to the patient the purpose of test and the need for a blood sample...
-
Upload
shannon-buck-cummings -
Category
Documents
-
view
216 -
download
3
Transcript of INSTRUCTIONS TO PATIENT Explain to the patient the purpose of test and the need for a blood sample...
INSTRUCTIONS TO PATIENT
Explain to the patient the purpose of test and the need for a blood sample to be drawn.
No fasting is required before the test.
PROCEDURE
A 3-5-ml blood sample is drawn through a vene puncture to a sodium floride oxalate tube.
Gloves are worn throughout the procedure
Apply pressure at Venopuncture site to arrest bleeding
Label the sample and transport to the Lab.
VALUE OF TEST To determine the degree of glucose control. Screening for DM. Distinguishing chemical forms from overt
Diabetes. Determining the relationship between
chronic high blood sugar level and pathological complications of DM.
Evaluating the efficiency of diabetic therapy.
Managing DM in Pregnancy.
PRINCIPLE OF GLYCATION Glycation of protein is a frequent
occurrence, but in the case of haemoglobin, a non-enzymatic seaction occurs betweeen glucose and N-end of the beta-chain. This form a Schiff base which is itself conserted to 1- deoxyfructose. This rearrangement is an example of an Amadori rearrangement.
CONTD.
When blood glucose levels are high, glucose
molecules attach to the Hb in red blood
cells. The longer hyperglycemia occurs in
blood, the more glucose binds to Hb in the
red blood cells and the higher the gycated
haemoglobin.
CONTD.
Once a haemoglobin molecule is glycated, it remains that way. A build-up of HbA1c WITHIN the red cell, therefore, reflects the average level of glucose to which the cell has been exposed during its life-cycle. Measuring HbA1c assesses the effectiveness of therapy by monitoring long-term serum glucose regulation.
LIMITATION
Although HbA1c levels are reliable indication
of recent average glycaemic control, it does
not provide information about the daily
pattern of blood glucose levels, Therefore
information required for logical adjustment of
insulin doses is derived from Routine RBS, FBS
test
CONTD.
More recent changes in glycaemia
(ie. Within the preceding 4-weeks or
so) will influence HbA1c level more
than glucose 12 or more weeks ago.
METHODS OF ESTIMATION
1. High performance liquid chromatography (HPLC): The HbA1c result is calculated as a ratio to total Hb by using a chromatogram
2. Radiolmmunoassays3. Enzymrimmuno assays4. Isoelectric to focusing5. Colorimetric method6. Microcoleum ion exchange technique7. Capillary electrophoresis8. Boronate afinity chromatography.
ADVANTANGES AND DISADVANTAGES OF VARIOUS ASSAY METHODS
ASSAY PRINCIPLE ADVANTAGES DISADVANTAGES
Ion Exchange Chromatography
HbA1c has lower isoelectric point and migrate faster than other Hb Componets
Can inspect chromograms for Hb Variants measurement with great precision
Variable interference from the Haemoglobinopatheis, HbF and Carbamylated Hb but the current ion in exchange assays correct for HbF & carbonlated Hb does not interfere.
contd
Boronate affinity
Glucose binds to m-aminophemlborononic acid
Minimal Interference from Haemoglobinopatheis, HbF and Carbamylated Hb.
Measures not only glucation of N-terminal valine on B chain but also B-chains glycated at other sites and glycated Alpha-chain.
contd
Immunoassays Antibody binds to glucose and between 4-10 N-terminal amino acids on b-chain.
Not affected by HbE, Hb D, or carbamylated Hb, Relatively easy to implement under many different format.
May be affected by haemoglonopatheis with altered amino acids or binding sites. Some Interferes with HbF
PRINCIPLES & PROCEDURES
Using kit of HbA1c. A haemolysed preparation of whole
blood is mixed continously for 5 minutes with a weak binding caton-exchange resin during this time the non-glycated haemoglobin, which consist of the bulk of the haemoglobin (HbAo) binds to the resin. After the mixing period a filter is used to separate the supernatant containing the
CONTD.
Glycohaemoglobin from the resin. The percent glycohaemoglobin is determine by measuring the absorbance at 415 nm (405 -420 nm acceptable) of the glycohaemoglobin fraction and the total haemoglobin fraction. The ration of the two absorbances gives the percent haemoglobin.
CONTD.
Using Ghb analyser. It uses low pressure cation exchange
chromatography in conjuction with gradient elution to separate human haemoglobin subtype and variants from haemolysed whole blood. The separated haemoglobin fraction are monitored by means of absorption of light at 415mn the chromatogram obtained is recorded
CONTD.
And stored by the on board computer. The analyser performs the analysis of the chromatogram and generate a printed report.
FACTORS THAT AFFECTS THE TEST RESULT
INCREASE DECREASE
Increase in HbF ↑
Haemolysis/bleeding
↓
Haemoglobinopatheis (HbS) Glucose -6- Pphosphate dehydrogenase deficency
Invalid result
contdSurgery, anaemia, blood transfusion, high erythrocyte turnover
Invalid Result
Liver disease ↓
Blood donation ↑
Vit B12 folate deficiency (longer rbc infespan)
↑
contd
Splenectomy (Increase rbc life-span)
↑
Pregnancy (Hormonal changes)
↑
Renal failure(dialysis)
↓
ESTIMATED AVERAGE GLUCOSE (EAG) This term is used to understand the
approximate relationship between HbA1c and glucose Concentration.
Formular: eAG (mg/dl)=(28.7xHbA1c)-46.7
eAG (mmollL) = (1.59 x HbA1c) – 2.59
NORMAL RANGE:
Varies with different Lab but the reference laboratory value is:-
Non-diabetic adult – 2.2-5.0%Diabetic adult: 7% (ADA guideline).
RESULT INTERPRETATIONPossible meaning of Abnormal result
INCREASE DECREASE
Alcohol Chronic loss of blood
Hyperghycemia Chronic renal failure
Lead poisioning Haemolytic Anaemia
Newly diagnose DM Sickle-cell anaemia
contd
Poor DM control Thalassemia
Pregnancy
RECOMMENDATIONS
Management goals should be aimed at preventing the
development of these complications and/or delaying the
onset of these complications for a prolonged or healthy life,
therefore a test of this nature (HbA1c) is highly
recommended for adequate management control of DM.
It should be performed at least twice a year in patients who
are meeting treatment goal and who have stable glycerinic
control.
CONTD.
Quarterly in patient whose therapy has changed or who are not meeting glycemic goals.
As needed to assist with decision-making on therapy changes.
Glycernic goals should be individualized, more stringent value ( less than 6%) reduce complications.
.
CONCLUSION Diabetes is now affecting many in
the work place, it has a major and deleterious impact on both individual and national productivity. The socio-economic consequences of diabetes and its complications could have a seriously negative impact in the economics of developed and developing nation.
CONTD. DM is a world health Challenge and
the complications such as Retinopathy, neuropathy,Nephropathy, Skin lesions (ulcer), diabetic Keto acidosis can be life threatening and difficult to reverse .
REFERENCES:
Oxford hand book of clinical and Laboratory Investigations by Drew Provan & Andrew Krentz (2002).
McGraw-Hills Manual of Laboratory & Diagnostic test (Denis D. Willson 1976).
Blacks Medical Dictionary 41st Edition (2005) Huisman T.H , Mantis E.A Dozy A (1958) Chromatography of Haemoglobin types on
Carbozymethylcellulose. Clin. Med. 52 (2): 312 -327 Koenig R.J , Peterson C.M, Jones R.L,( et al 1976 )
“Correlation of glucose regulation and Haemoglobin A1c in diabetes mellitus” N.Engl. J. Med. 295 (8): 417 -420.